Prothena | PRTA - Pre Tax Profit

Stock Price
10.63
Daily Change
-0.02 -0.19%
Monthly
8.36%
Yearly
3.61%
Q2 Forecast
9.55

Prothena reported $-21.58M in Pre-Tax Profit for its fiscal quarter ending in December of 2025.





Pre Tax Profit Change Date
Acadia Pharmaceuticals USD 26.32M 18.28M Dec/2025
Agios Pharmaceuticals USD -109.06M 5.62M Dec/2025
Akebia Therapeutics USD -11.24M 12.39M Dec/2025
ALKERMES USD 100.74M 4.1M Sep/2025
Alnylam Pharmaceuticals USD 161.14M 77.83M Dec/2025
Amgen USD 3.92B 2.35B Sep/2025
Biogen USD 557.3M 186.7M Sep/2025
BioMarin Pharmaceutical USD -26.32M 324.19M Sep/2025
Exelixis USD 252.69M 275K Dec/2025
Immunic USD -21.38M 8.2M Jun/2024
Incyte USD 389.94M 92.37M Dec/2025
Ionis Pharmaceuticals USD -228M 99M Dec/2025
MacroGenics USD -14.93M 31.75M Dec/2025
Nektar Therapeutics USD -34.7M 2.35M Dec/2025
Neurocrine Biosciences USD 239.4M 52.4M Dec/2025
Prothena USD -21.58M 15.33M Dec/2025
Regeneron Pharmaceuticals USD 1.76B 244.6M Sep/2025
Ultragenyx Pharmaceutical USD -128M 51.54M Dec/2025
Vertex Pharmaceuticals USD 1.3B 15.8M Sep/2025
Xoma USD 15.98M 24.58M Jun/2024